Last verified: May 2026
The Statutory Definition
Georgia’s "low THC oil" is defined in O.C.G.A. § 16-12-191 as oil containing:
- No more than 5% THC by weight; and
- Cannabidiol (CBD) content equal to or greater than the THC content.
Both elements must be satisfied. A product at 4% THC with 3% CBD does not qualify (CBD must be ≥ THC). A product at 6% THC with 7% CBD also does not qualify (THC must not exceed 5%). The cap is therefore meaningfully tighter than a simple percentage limit.
Comparison to Other State Programs
Georgia’s 5% THC cap is the lowest of any state medical-cannabis program. Comparative caps:
- Most state programs — no statutory hard THC cap on flower or concentrates; ADH-style potency-testing requirements with results on labels.
- Mississippi — 30% on flower, 60% on concentrates (the only other state with statutory potency caps; both substantially higher than Georgia’s).
- Florida — no statutory cap; flower up to 30%+ THC routine.
- Iowa — uniquely measures by total THC milligrams (4.5g per 90 days).
- Georgia — 5% THC by weight, CBD ≥ THC.
Why This Matters for Patients
The 5% cap excludes most products patients see in press coverage of medical cannabis:
- Most cannabis flower in legal-rec states tests at 18%–30%+ THC.
- Most concentrates test at 60%–90%+ THC.
- Most edibles in other states are dosed at 5–10 mg THC per serving with little or no CBD.
None of these meet Georgia’s 5%-with-CBD≥THC standard. Georgia patients who research cannabis treatments online routinely encounter products and dosing protocols that don’t exist in the Georgia legal market.
The Functional Effect
Patients dose by larger volume of product than they would in higher-cap states. A patient dosing 20 mg THC daily (a moderate chronic-pain or PTSD dose):
- In Georgia: a patient takes ~0.4 g of 5% oil per day = ~0.4 ml in dropper terms. The 20 fl oz (~592 ml) possession ceiling represents ~1,500 days of dosing — effectively a multi-year supply for typical use, though high-dose patients use volume more quickly.
- In a higher-cap state: a patient takes ~0.07 g of 30% oil per day = ~0.07 ml.
The volume-versus-mass calibration explains why the 20 fl oz possession ceiling sounds large but isn’t actually generous in milligram-of-THC terms.
The CBD ≥ THC Requirement
The CBD ≥ THC requirement was a deliberate 2015 design choice intended to ensure Georgia’s low-THC oil would be primarily CBD-driven. CBD has FDA-approved indications (Epidiolex for certain pediatric epilepsy syndromes) and was politically more defensible in the 2015 legislative environment than THC-rich preparations.
The requirement also aligns the Georgia program with the original 2015 use case of pediatric epilepsy, where CBD-dominant treatment ratios are clinically appropriate. For adult chronic-pain or PTSD patients, however, the CBD ≥ THC requirement may not match clinical preference; many patients in higher-cap states use THC-dominant ratios.
SB 220 (2026) Would Replace the Percentage Cap with a Milligram Ceiling
SB 220 (Sen. Matt Brass + Rep. Mark Newton MD), pending Gov. Kemp’s ~May 12, 2026 signature, would substantially restructure the THC limit:
- Removes the 5% THC potency cap. Products would no longer be restricted by percentage.
- Removes the CBD ≥ THC requirement. Products could be THC-dominant.
- Imposes a 12,000 mg total-THC possession ceiling at any one time.
- Caps individual product packages at 1,200 mg.
If signed, Georgia would move from a percentage-cap model (the most restrictive in the country) to a milligram-cap model (similar to Iowa’s structure but at substantially higher milligram volume). 12,000 mg total THC = ~600 servings at 20 mg each = ~20 months of moderate-dose chronic-pain treatment. See SB 220 page.
Practical Patient Notes
- Always verify lab-test results showing ≤5% THC and CBD ≥ THC. The Class 1 + Class 2 producers test all batches.
- Out-of-state cannabis products (including those purchased in Florida, Maryland, Missouri, etc.) almost certainly do not qualify under Georgia’s 5% standard. Bringing them into Georgia is a federal felony regardless.
- Hemp-derived products at ≤0.3% total THC are separately legal under Georgia’s hemp framework (HB 213 / SB 494) but are not the same regulated product as Haleigh’s Hope Act low-THC oil — different statutes, different testing standards, different distribution channels.
For in-depth cannabis education, dosing guides, safety information, and research summaries, visit our partner site TryCannabis.org